| Description | IRAK4-IN-8 (VI-177) is an IRAK4 inhibitor for the study of diseases associated with cancer and inflammation. |
| molecular weight | 499.54 |
| Molecular formula | C23H23F2N7O2S |
| CAS | 2033070-97-0 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 20 mg/mL (45.26 mM), Sonication is recommended. |
| References | 1. Vanessa Taylor, et al. Compounds and method for treating cytokine release syndrome. WO2021026451A1. |